Willison HJ, Jacobs BC, van Doorn PA. Guillain-Barré syndrome. The Lancet. 2016;388(10045):717-27.

Sejvar JJ, Baughman AL, Wise M, Morgan OW. Population incidence of Guillain-Barré syndrome: a systematic review and meta-analysis. Neuroepidemiology. 2011;36(2):123-33.

Lehmann HC, Hughes RA, Kieseier BC, Hartung HP. Recent developments and future directions in Guillain‐Barré syndrome. Journal of the Peripheral Nervous System. 2012;17(s3):57-70.

Sejvar JJ, Kohl KS, Gidudu J, et al. Guillain-Barré syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine. 2011;29(3):599.

Chanson J-B, Echaniz-Laguna A. Early electrodiagnostic abnormalities in acute inflammatory demyelinating polyneuropathy: a retrospective study of 58 patients. Clinical Neurophysiology. 2014;125(9):1900-5.

Albertí MA, Alentorn A, Martínez‐Yelamos S, et al. Very early electrodiagnostic findings in Guillain‐Barré syndrome. Journal of the Peripheral Nervous System. 2011;16(2):136-42.

Chan YC, Punzalan‐Sotelo AM, Kannan TA, et al. Electrodiagnosis of reversible conduction failure in Guillain–Barré syndrome. Muscle & nerve. 2017;56(5):919-24.

Fokke C, van den Berg B, Drenthen J, Walgaard C, van Doorn PA, Jacobs BC. Diagnosis of Guillain-Barré syndrome and validation of Brighton criteria. Brain. 2014;137(1):33-43.

Roodbol J, De Wit M, Walgaard C, de Hoog M, Catsman-Berrevoets C, Jacobs B. Recognizing Guillain-Barré syndrome in preschool children. Neurology. 2011;76(9):807-10.

Van den Berg B, Walgaard C, Drenthen J, Fokke C, Jacobs BC, Van Doorn PA. Guillain–Barré syndrome: pathogenesis, diagnosis, treatment and prognosis. Nature Reviews Neurology. 2014;10(8):469-82.

Wu X, Shen D, Li T, et al. Distinct clinical characteristics of pediatric Guillain-Barré syndrome: a comparative study between children and adults in Northeast China. PLoS One. 2016;11(3):e0151611.

Dourado M, Félix R, Da Silva W, Queiroz J, Jeronimo S. Clinical characteristics of Guillain–Barré syndrome in a tropical country: a Brazilian experience. Acta neurologica scandinavica. 2012;125(1):47-53.

Domínguez-Moreno R, Tolosa-Tort P, Patiño-Tamez A, et al. Mortalidad asociada al diagnóstico de síndrome de Guillain-Barré en adultos ingresados en instituciones del sistema sanitario mexicano. Rev Neurol. 2014;58(1):4-10.

van den Berg B, Bunschoten C, van Doorn PA, Jacobs BC. Mortality in Guillain-Barré syndrome. Neurology. 2013;80(18):1650-4.

Papri N, Islam Z, Leonhard SE, Mohammad QD, Endtz HP, Jacobs BC. Guillain–Barré syndrome in low-income and middle-income countries: challenges and prospects. Nature Reviews Neurology. 2021;17(5):285-96.

Karimzadeh P, Bali MKB, Nasehi MM, Otaghsara SMT, Ghofrani M. Atypical findings of Guillain-Barré syndrome in children. Iranian Journal of Child Neurology. 2012;6(4):17.

Das S, Khan R, Alam S, Chowdhury N, Das P. Study on Electrophysiological Findings of Guillain Barre Syndrome Patients Attending the Department of Neurology in BSMMU. Mymensingh medical journal: MMJ. 2018;27(3):631-40.

Kumar P. Mimics and Chameleons in Guillain-Barré Syndrome. Cureus. 2021;13(9).

Wang Y, Sun S, Zhu J, Cui L, Zhang H-L. Biomarkers of Guillain-Barré syndrome: some recent progress, more still to be explored. Mediators of inflammation. 2015;2015.

Pagana K, Pagana T, Pagana T. Mosby's Diagnostic & Laboratory Test Reference. 14th edn St. Louis, Mo: Elsevier. 2019.

DiCapua DB, Lakraj AA, Nowak RJ, Robeson K, Goldstein J, Patwa H. Relationship between cerebrospinal fluid protein levels and electrophysiologic abnormalities in Guillain–Barré syndrome. Journal of Clinical Neuromuscular Disease. 2015;17(2):47-51.

Bourque PR, Brooks J, Warman-Chardon J, Breiner A. Cerebrospinal fluid total protein in Guillain–Barré syndrome variants: correlations with clinical category, severity, and electrophysiology. Journal of Neurology. 2020;267(3):746-51.